Sandra E. Dillahunt

Array ( [id] => 9570043 [patent_doc_number] => 20140187756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'Methods of preparing antibody-active agent conjugates' [patent_app_type] => utility [patent_app_number] => 14/181649 [patent_app_country] => US [patent_app_date] => 2014-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 30798 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14181649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568629 [patent_doc_number] => 20140186342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 14/148556 [patent_app_country] => US [patent_app_date] => 2014-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24419 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16651230 [patent_doc_number] => 10928402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Treatment of spontaneous preterm birth [patent_app_type] => utility [patent_app_number] => 14/655705 [patent_app_country] => US [patent_app_date] => 2013-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15975 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9448939 [patent_doc_number] => 20140120108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'MUTANT PTP ALPHA GENE GROUP IN MALIGNANT TUMORS AND PRODUCTION METHOD' [patent_app_type] => utility [patent_app_number] => 14/140455 [patent_app_country] => US [patent_app_date] => 2013-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4694 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14140455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11217785 [patent_doc_number] => 09446104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Method of inducing a proinflammatory immune response to human α-lactalbumin' [patent_app_type] => utility [patent_app_number] => 14/132962 [patent_app_country] => US [patent_app_date] => 2013-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 4332 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10398119 [patent_doc_number] => 20150283127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'SAQUINAVIR-NO FOR IMMUNOMODULATION' [patent_app_type] => utility [patent_app_number] => 14/443402 [patent_app_country] => US [patent_app_date] => 2013-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6087 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9369833 [patent_doc_number] => 20140079705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-20 [patent_title] => 'BISPECIFIC IMMUNOBINDERS DIRECTED AGAINST TNF AND IL-17' [patent_app_type] => utility [patent_app_number] => 14/082502 [patent_app_country] => US [patent_app_date] => 2013-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 65922 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14082502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9537120 [patent_doc_number] => 20140161767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'FOLLICLE-STIMULATING HORMONE (FSH)/LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 14/080185 [patent_app_country] => US [patent_app_date] => 2013-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 33623 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14080185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9510920 [patent_doc_number] => 20140147411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'METHODS OF TREATING CANCER AND TESTING MUTATION ZYGOSITY RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 14/077348 [patent_app_country] => US [patent_app_date] => 2013-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6906 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14077348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10412733 [patent_doc_number] => 20150297743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET' [patent_app_type] => utility [patent_app_number] => 14/440483 [patent_app_country] => US [patent_app_date] => 2013-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35263 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9545504 [patent_doc_number] => 20140170152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'IMMUNOBINDERS DIRECTED AGAINST TNF' [patent_app_type] => utility [patent_app_number] => 14/073479 [patent_app_country] => US [patent_app_date] => 2013-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37313 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15848213 [patent_doc_number] => 10639367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Composition comprising cytokine macro-aggregates [patent_app_type] => utility [patent_app_number] => 14/440413 [patent_app_country] => US [patent_app_date] => 2013-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 24 [patent_no_of_words] => 12306 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12561249 [patent_doc_number] => 10015980 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-10 [patent_title] => Methods and formulations promoting tissue/organ regeneration, longevity and healthspan [patent_app_type] => utility [patent_app_number] => 14/060494 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22869 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14060494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17799062 [patent_doc_number] => 11413329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-16 [patent_title] => Cancer cell trap [patent_app_type] => utility [patent_app_number] => 14/436601 [patent_app_country] => US [patent_app_date] => 2013-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 19969 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9330128 [patent_doc_number] => 20140056910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'THERAPEUTIC AGENT FOR CANCER HAVING REDUCED SENSITIVITY TO MOLECULAR TARGET DRUG AND PHARMACEUTICAL COMPOSITION FOR ENHANCING SENSITIVITY TO MOLECULAR TARGET DRUG' [patent_app_type] => utility [patent_app_number] => 14/057398 [patent_app_country] => US [patent_app_date] => 2013-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9550 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408952 [patent_doc_number] => 09556243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Methods for making cytokine compositions from tissues using non-centrifugal methods' [patent_app_type] => utility [patent_app_number] => 14/050950 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 13854 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14050950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10361090 [patent_doc_number] => 20150246095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA' [patent_app_type] => utility [patent_app_number] => 14/430405 [patent_app_country] => US [patent_app_date] => 2013-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13484 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14430405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16030745 [patent_doc_number] => 10677783 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-09 [patent_title] => Method for evaluating effect of cytokine on metabolic activity of cytochrome P450, and drug screening method [patent_app_type] => utility [patent_app_number] => 14/431986 [patent_app_country] => US [patent_app_date] => 2013-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 15036 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 696 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10325764 [patent_doc_number] => 20150210768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'Methods and Compounds for Preventing, Treating and Diagnosing an Inflammatory Condition' [patent_app_type] => utility [patent_app_number] => 14/423751 [patent_app_country] => US [patent_app_date] => 2013-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30599 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9362700 [patent_doc_number] => 20140072573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'METHOD OF TREATING RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 14/018879 [patent_app_country] => US [patent_app_date] => 2013-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8103 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14018879 [rel_patent_id] =>[rel_patent_doc_number] =>)